Complement factor D, a novel serine protease
- PMID: 8845746
- PMCID: PMC2143395
- DOI: 10.1002/pro.5560050401
Complement factor D, a novel serine protease
Abstract
Factor D is unique among serine proteases in that it requires neither enzymatic cleavage for expression of proteolytic activity nor inactivation by a serpin for its control. Regulation of factor D activity is instead attained by a novel mechanism that depends on reversible conformational changes for expression and control of catalytic activity. These conformational changes are believed to be induced by the single natural substrate, C3bB, and to result in realignment of the catalytic triad, the specificity pocket, and the nonspecific substrate binding site, all of which have atypical conformations. Mutational studies have defined structural determinants responsible for these unique structural features of factor D and for the resultant low reactivity with synthetic esters.
Similar articles
-
Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity.J Mol Biol. 1998 Oct 9;282(5):1061-81. doi: 10.1006/jmbi.1998.2089. J Mol Biol. 1998. PMID: 9753554
-
Crystal structure of a complement factor D mutant expressing enhanced catalytic activity.J Biol Chem. 1995 Oct 13;270(41):24399-405. doi: 10.1074/jbc.270.41.24399. J Biol Chem. 1995. PMID: 7592653
-
Mutational analysis of the substrate binding site of human complement factor D.Biochemistry. 1994 Dec 6;33(48):14393-9. doi: 10.1021/bi00252a004. Biochemistry. 1994. PMID: 7981199
-
Structural biology of the alternative pathway convertase.Immunol Rev. 2001 Apr;180:123-35. doi: 10.1034/j.1600-065x.2001.1800111.x. Immunol Rev. 2001. PMID: 11414354 Review.
-
The atypical serine proteases of the complement system.Adv Immunol. 1998;69:249-307. Adv Immunol. 1998. PMID: 9646846 Review. No abstract available.
Cited by
-
Complement component C3: A structural perspective and potential therapeutic implications.Semin Immunol. 2022 Jan;59:101627. doi: 10.1016/j.smim.2022.101627. Epub 2022 Jun 25. Semin Immunol. 2022. PMID: 35760703 Free PMC article. Review.
-
Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D.ACS Med Chem Lett. 2018 Apr 24;9(5):490-495. doi: 10.1021/acsmedchemlett.8b00104. eCollection 2018 May 10. ACS Med Chem Lett. 2018. PMID: 29795765 Free PMC article.
-
Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation.Hypertens Res. 2023 Jul;46(7):1759-1770. doi: 10.1038/s41440-023-01300-3. Epub 2023 May 15. Hypertens Res. 2023. PMID: 37188751 Free PMC article.
-
MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked.Sci Rep. 2016 Aug 18;6:31877. doi: 10.1038/srep31877. Sci Rep. 2016. PMID: 27535802 Free PMC article.
-
Complement: an overview for the clinician.Hematol Oncol Clin North Am. 2015 Jun;29(3):409-27. doi: 10.1016/j.hoc.2015.02.001. Epub 2015 Apr 4. Hematol Oncol Clin North Am. 2015. PMID: 26043382 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous